Sandoz to build biologics plant in Slovenia
European Pharmaceutical Review
MARCH 13, 2023
Full operations is provisionally planned for late 2026. The company also recently announced an additional €50 million investment to expand its European-based antibiotics production network. This brings the total new investment commitment to the network in the past few years to €250 million.
Let's personalize your content